Jump to content

Kalipada Pahan

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Hillelfrei (talk | contribs) at 16:37, 14 May 2020 (Reverted 1 edit by 2601:241:8680:E830:406F:A36F:9FD7:B49C (talk): Disrupt ref (TW)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Kalipada Pahan
Born (1964-02-19) 19 February 1964 (age 60)
Midnapore, West Bengal, India
Occupation(s)Professor, Neuroscientist
Known forResearch on statins (cholesterol-lowering drugs) and cinnamon

Kalipada Pahan is a Professor of Neurological Sciences, Biochemistry and Pharmacology, and the Floyd A. Davis, M.D., Endowed Chair in Neurology at the Rush University Medical Center. He is also a research career scientist at the Department of Veterans Affairs, Jesse Brown VA Medical Center.[citation needed] He is an eminent Indian American neuroscientist involved in translational research on multiple sclerosis, Parkinson's disease, Alzheimer's disease, dementia, and Batten disease.[1] He is known for his research on statins, cholesterol-lowering drugs. He first explored the application of statins in suppressing the inflammatory events in microglia, astroglia and macrophages.[2] This finding has revolutionized the research on statin drugs. Later his lab has shown that statins may be beneficial in protecting neurons and improving locomotor activities in Parkinson's disease by suppressing the activation of p21/Ras.[3] His lab is also famous for research on cinnamon where they have described that this commonly-used natural spice may be beneficial for different brain disorders including improving memory and learning of poor learners. Recently his lab has delineated a unique crosstalk between fat and memory in which the lipid-lowering transcription factor PPARalpha controls the formation of hippocampal memory via transcriptional regulation of CREB (Roy et al., 2013, Cell Reports 4: 724-737), suggesting a possible reason for the connection between excess belly fat and memory loss.[4]

He has written many book chapters and published more than 180 articles in many peer-reviewed journals including Journal of Biological Chemistry, Journal of Immunology, Journal of Neuroscience, Cell Death and Differentiation, Proceedings of the National Academy of Sciences of the USA, Journal of Clinical Investigation, Science Signaling, Cell Reports, Cell Metabolism, and Nature Chemical Biology. He is the recipient of "D. H. Reinhardt Scholar" award from the University of Nebraska Medical Center (UNMC) College of Dentistry, the "Silver U" award from the UNMC Chancellor's council, and the outstanding teaching award from the UNMC College of Dentistry. He also received the Zenith Fellows Award from the Alzheimer's Association.[5][better source needed]

References

  1. ^ "Home". Pahanlab.com. Retrieved 3 February 2014.
  2. ^ K Pahan (1 December 1997). "Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages". 100 (11). F G Sheikh, A M Namboodiri and I Singh. J Clin Invest: 2671–2679. doi:10.1172/JCI119812. PMC 508470. PMID 9389730. Retrieved 3 February 2014. {{cite journal}}: Cite journal requires |journal= (help)
  3. ^ Ghosh A (28 October 2009). "Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease". J. Neurosci. 29 (43). Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K.: 13543–56. doi:10.1523/JNEUROSCI.4144-09.2009. PMC 2862566. PMID 19864567.
  4. ^ "Neurological researchers find fat may be linked to memory loss". ScienceDaily. 9 October 2019. Retrieved 22 August 2019.
  5. ^ @Rushuniversity (14 February 2017). "Kalipada Pahan PhD, the Floyd A. Davis, MD Professor of Neurology, has received the Zenith Fellows Award from the @alzassociation" (Tweet). Retrieved 22 August 2019 – via Twitter.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Kalipada_Pahan&oldid=956668590"